Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia

J Infect Dis. 1993 Oct;168(4):955-60. doi: 10.1093/infdis/168.4.955.

Abstract

To assess the role of tumor necrosis factor (TNF) in the appearance of soluble TNF receptors (sTNFRs), 20 consecutive patients with a clinical diagnosis of sepsis were studied as were 7 chimpanzees after administration of endotoxin (4 ng/kg) with or without pentoxifylline. The patients had markedly elevated serum levels of sTNFR-p55 and sTNFR-p75 compared with healthy controls (P < .0001 for both receptors). The levels of both soluble receptors correlated with simultaneously measured immunoreactive TNF concentrations (p55: r = .63, P < .01; p75: r = .69, P < .001). In the chimpanzees, endotoxin induced subsequent rises in the serum concentrations of TNF and sTNFRs. Although pentoxifylline reduced the TNF response to intravenous endotoxin to 20% (P < .05), the appearance of sTNFRs was only moderately inhibited (sTNFR-p55 to 79% on average, P < .05; sTNFR-p75 to 77%, P = .12). These results indicate that TNF either does not play an important role in the appearance of sTNFRs in systemic infection or that a small amount of TNF remaining in the circulation after some bacterial challenges is sufficient to preserve the secretion of its soluble receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Analysis of Variance
  • Animals
  • Endotoxins / toxicity*
  • Escherichia coli
  • Female
  • Humans
  • Kinetics
  • Male
  • Middle Aged
  • Pan troglodytes
  • Pentoxifylline / pharmacology
  • Receptors, Cell Surface / biosynthesis*
  • Receptors, Tumor Necrosis Factor
  • Reference Values
  • Sepsis / blood
  • Sepsis / metabolism*
  • Shock, Septic / blood
  • Shock, Septic / metabolism*
  • Time Factors
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Endotoxins
  • Receptors, Cell Surface
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Pentoxifylline